Mumbai, India — 19-20th September — ALWIS Solution is proud to announce the successful conclusion of its participation at the DIA India Annual Meeting 2025, one of the most influential global platforms for advancing life sciences and healthcare innovation. Over the course of the event, our team engaged with leading [...]
We are delighted to announce that Abdul Rahim, Founder Director of ALWIS Solutions Ltd, will be a featured speaker at the DIA India Annual Meeting 2025, taking place September 19–20 at the NESCO Center in Mumbai. At this premier life sciences forum, focused on “Innovation Through Integration: Shaping the Future [...]
Introducing CHATBOT — the latest innovation in our platform. Built with conversational AI, CHATBOT helps you move beyond search and manual review. You can now surface relevant insights, identify patterns, and extract key information — all through a seamless, intuitive experience. Experience faster, smarter pharmacovigilance with CHATBOT. [...]
Alwis Group is proud to be a Gold Sponsor at the upcoming WHY Summit – Future of Pharmacovigilance World Tour / World Drug Safety Summit in Basel, Switzerland. This global event will bring together leading experts and innovators to discuss the evolving landscape of drug safety and pharmacovigilance, aligning with [...]
ALWIS Group proudly participated in this high-impact summit focused on advancing drug safety through innovation and collaboration. The two-day event brought together global pharmacovigilance leaders, regulatory experts, and tech pioneers to discuss the evolving landscape of safety monitoring. At the heart of our presence was ReTrans Enterprise, our flagship AI-powered [...]
At the World Drug Safety Congress Europe, ALWIS Solutions Limited stands out as a Gold Sponsor, showcasing its commitment to advancing pharmacovigilance through innovative technology. With over a decade of experience in life sciences, ALWIS specializes in cloud-based platforms that streamline drug safety processes for pharmaceutical companies, Contract Research Organizations [...]
At the Global Drug Safety & PV Outsourcing Summit 2024 held in Mumbai, ALWIS Group participated as a Silver Sponsor, highlighting its commitment to advancing pharmacovigilance through innovative AI-driven solutions. While specific details of their presentation are not publicly available, ALWIS Group’s showcased products included: [...]
We’re proud to announce that a Fortune 500 pharmaceutical leader has officially gone live with ReTrans, our AI-driven literature surveillance platform. This milestone not only reinforces the growing global trust in ALWIS Group’s technological innovations but also showcases the scalability, compliance, and efficiency of ReTrans in enterprise pharmacovigilance environments. As [...]